Search for: "Grant v. Bristol-Myers Squibb"
Results 101 - 120
of 157
Sorted by Relevance
|
Sort by Date
18 Feb 2020, 4:00 am
A patent defines a monopoly granted to an inventor in consideration of the disclosure of the invention to the public. [read post]
18 Jan 2017, 7:35 am
Bristol-Myers Squibb Co. v. [read post]
27 Jan 2017, 12:52 pm
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
19 Apr 2022, 8:00 am
Apple Inc. v. [read post]
15 Aug 2021, 11:51 pm
Bristol-Myers Squibb The following case illustrates licence sought for Sprycel® which is used in cancer treatment On March 4, 2013 the Controller rejected BDR Pharmaceuticals’ (BDR) application for a compulsory license for the cancer drug Sprycel®. [read post]
17 May 2021, 1:12 pm
“And Trimble is headquartered in California, connecting California to Trimble’s claims, which is a consideration the Court in Ford found relevant in distinguishing its earlier decision in Bristol-Myers. [read post]
17 Nov 2010, 1:48 am
(Patents Post Grant Blog) US: University inventions, Stanford vs Roche (IPEG) US: What ultimately matters in deciding the ‘gene patenting’ issue? [read post]
7 Nov 2014, 5:52 am
Ellis v. [read post]
21 Apr 2024, 2:35 pm
(quoting Bristol-Myers Squibb Co. v. [read post]
11 Mar 2019, 10:15 am
Bristol-Myers Squibb Co., 919 F.3d 699 (2d Cir. 2019) followed suit and unanimously affirmed snap removal as a procedural vehicle to remove to federal court. [read post]
10 Jul 2008, 5:31 pm
Bristol-Myers Squibb Co., 121 F. [read post]
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
11 Nov 2009, 4:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/ Highlights this week included: EU: Generics producers: Criminal sanctions can stop counterfeit drugs (IP Watch) Prandin (Repaglinide) – US: Federal Circuit grants stay of preliminary relief pending full appellate review: Novo Nordisk v Caraco (Patently-O) General Eduardo Pisani of Bristol-Myers Squibb is… [read post]
12 Jun 2018, 6:56 am
The agency’s argument that the regulation leaves the decision up to the employer was unavailing, the court explained, under the competitor standing doctrine and had already been rejected in earlier cases, such as Bristol-Myers Squibb Co. v. [read post]
10 Sep 2012, 7:28 pm
Mich. 1996); Bristol-Myers Squibb Co. v. [read post]
5 Oct 2020, 9:01 pm
Should the Court now adopt a restrictive interpretation of the phrase “arises out of or relate to,” it would limit specific personal jurisdiction in a way that would benefit corporate manufacturers at the expense of consumers.Justice Sonia Sotomayor articulated this concern in her dissent in Bristol-Myers Squibb v. [read post]
3 Mar 2009, 5:55 am
What caught my eye, however, was the court's description of the order appealed from, viz, one granting "those parts of the motion of defendants seeking dismissal of the negligence and slander causes of action and the punitive damages claim. [read post]
4 Oct 2023, 10:00 pm
The Plaintiffs in the remaining five lawsuits (Merck, Bristol Myers Squibb, PhRMA and other trade associations, Janssen pharmaceutical, and Boehringer Ingelheim) might similarly amend their complaints to note that their drugs were in fact selected, and that they were compelled to sign contracts with the CMS. [read post]
6 May 2016, 12:30 pm
Bean v. [read post]
2 Nov 2009, 1:24 pm
At the Wall Street Journal, Dow Jones Newswire’s Kristina Peterson addresses the Court’s denial of cert. in a drug-patent dispute between generic drug manufacturer Apotex Corp. and patent-holders Sanofi-Aventis and Bristol-Myers Squibb, while the Associated Press has coverage of the Court’s decision not to hear an appeal to stop the release of documents relating to sexual abuse lawsuits against Roman Catholic priests in… [read post]
